Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

NCT01951885 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Biphenotypic Leukemia
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
Non-Hodgkin Lymphoma
Hodgkins Disease
Chronic Lymphocytic Leukemia
Multiple Myeloma

Interventions

DRUG: tacrolimus
DRUG: methotrexate
DRUG: Mycophenolate mofetil
DRUG: Methotrexate (low dose)

Sponsor

Case Comprehensive Cancer Center